Evolutionary expansion of the human neocortex underlies many of our unique mental abilities. This expansion has been attributed to the increased proliferative potential 1,2 of radial glia (RG; neural stem cells) and their subventricular dispersion from the periventricular niche 3-5 during neocortical development. Such adaptations may have evolved through gene expression changes in RG. However, whether or how RG gene expression varies between humans and other species is unknown. Here we show that the transcriptional profiles of human and mouse neocortical RG are broadly conserved during neurogenesis, yet diverge for specific signalling pathways. By analysing differential gene co-expression relationships between the species, we demonstrate that the growth factor PDGFD is specifically expressed by RG in human, but not mouse, corticogenesis. We also show that the expression domain of PDGFRb, the cognate receptor 6,7 for PDGFD, is evolutionarily divergent, with high expression in the germinal region of dorsal human neocortex but not in the mouse. Pharmacological inhibition of PDGFD-PDGFRb signalling in slice culture prevents normal cell cycle progression of neocortical RG in human, but not mouse. Conversely, injection of recombinant PDGFD or ectopic expression of constitutively active PDGFRb in developing mouse neocortex increases the proportion of RG and their subventricular dispersion. These findings highlight the requirement of PDGFD-PDGFRb signalling for human neocortical development and suggest that local production of growth factors by RG supports the expanded germinal region and progenitor heterogeneity of species with large brains.
Evolutionary expansion of the human neocortex underlies many of our unique mental abilities. This expansion has been attributed to the increased proliferative potential 1,2 of radial glia (RG; neural stem cells) and their subventricular dispersion from the periventricular niche [3] [4] [5] during neocortical development. Such adaptations may have evolved through gene expression changes in RG. However, whether or how RG gene expression varies between humans and other species is unknown. Here we show that the transcriptional profiles of human and mouse neocortical RG are broadly conserved during neurogenesis, yet diverge for specific signalling pathways. By analysing differential gene co-expression relationships between the species, we demonstrate that the growth factor PDGFD is specifically expressed by RG in human, but not mouse, corticogenesis. We also show that the expression domain of PDGFRb, the cognate receptor 6, 7 for PDGFD, is evolutionarily divergent, with high expression in the germinal region of dorsal human neocortex but not in the mouse. Pharmacological inhibition of PDGFD-PDGFRb signalling in slice culture prevents normal cell cycle progression of neocortical RG in human, but not mouse. Conversely, injection of recombinant PDGFD or ectopic expression of constitutively active PDGFRb in developing mouse neocortex increases the proportion of RG and their subventricular dispersion. These findings highlight the requirement of PDGFD-PDGFRb signalling for human neocortical development and suggest that local production of growth factors by RG supports the expanded germinal region and progenitor heterogeneity of species with large brains.
Radial glia are the physical substrate 8 and progenitor population that underlie production of most cells in human neocortex 2 . We sought to determine a general transcriptional 'signature' of human neocortical RG (hRG) as a starting point for identifying genes that may regulate uniquely human aspects of cortical development. We and others have previously shown that gene co-expression analysis of heterogeneous tissue samples can deconvolve transcriptional signatures of distinct cell types without cell isolation or purification 9, 10 . Because prenatal samples of human neocortex are scarce, we developed a novel strategy called Gene Co-expression Analysis of Serial Sections (GCASS) that exploits variation in cellular abundance across serial sections of a single tissue sample to reveal celltype-specific patterns of gene expression ( Fig. 1a-c and Extended Data Fig. 1 ; see Supplementary Information for methods, rationale and further discussion). We applied GCASS to 87 150-mm sections of a single human cortical sample from gestational week 14.5 (GW14.5, corresponding to peak layer V neurogenesis 11 ; Supplementary Table 1 ) and identified 55 modules of co-expressed genes. Six modules overlapped significantly with a set of genes that we determined were expressed significantly higher in fluorescence-activated cell sorting (FACS)-sorted mouse RG (mRG) versus intermediate progenitor cells (FACS mRG; Extended Data Fig. 1 and Supplementary Table 2 ), suggesting that they might represent transcriptional signatures of hRG ( Fig. 1d ). Analysis of laser-microdissected samples from three independent transcriptomic data sets 12, 13 confirmed that genes in these modules are most highly expressed in the ventricular zone (VZ) and subventricular zone (SVZ) of developing human neocortex, where both ventricular (vRG) and outer subventricular (oRG) subtypes of RG reside 4 (Extended Data Fig. 2 ).
To produce a consensus transcriptional signature for GW14.5 hRG, we first summarized each of these six modules by its first principal component/module eigengene 14, 15 (ME) and calculated the Weighted Gene Co-expression Network Analysis 16 measure of intramodular gene connectivity, k ME 10,14 (see Fig. 1c ). k ME quantifies the extent to which a gene *These authors contributed equally to this work. 1These authors jointly supervised this work. , Genes with similar expression patterns are grouped into modules, which may reflect cell-type-specific gene co-expression 10 . c, The transcriptional signature of a module is defined as a list of genes ranked by their correlation to the module eigengene 14 . conforms to the characteristic expression pattern of a module and can predict gene expression specificity for individual cell types 10 . k ME values for the six modules were combined into a single measure (Z hRG ), with higher values predicting greater expression specificity for hRG ( Fig. 1e ). Genes with high Z hRG values included markers of neocortical RG such as SLC1A3 (GLAST1), VIM, SOX2, NOTCH1 and PAX6 ( Fig. 1e , blue lines). Genes with low Z hRG values included markers of committed neuronal lineages such as TBR1, FEZF2, RELN and SATB2 ( Fig. 1e , black lines). We performed in situ hybridization (ISH) and immunostaining on independent prenatal human neocortical samples for genes with high Z hRG values that have not, to our knowledge, previously been implicated in RG biology ( Fig. 1e , red lines and Extended Data Fig. 3 ). In all cases, expression of these genes was restricted to the VZ/SVZ ( Fig. 1f and Extended Data Fig. 3 ). These results indicate that GCASS can discern a general transcriptional signature of hRG from a single, heterogeneous tissue sample without cell labelling, isolation, or purification. Moreover, because the sample derives from a single individual, this strategy implicitly controls for genotype and developmental stage and has broad implications for the molecular analysis of rare tissue samples.
To establish the robustness of the hRG transcriptional signature, we analysed four additional prenatal human cortex gene expression data sets 12, 13 (see also http://www.brainspan.org/rnaseq/search/index.html) that were generated with diverse sampling strategies and technology platforms (Extended Data Table 1 ). In parallel, we also analysed three embryonic mouse cortex gene expression data sets 12, 17, 18 (largely embryonic day (E)14-14.5, corresponding to peak layer V neurogenesis 11 ; Extended Data Table 1 ) to establish a robust mRG transcriptional signature. For each data set, we constructed an unsupervised co-expression network, identified the module with the most significant overlap with the FACS mRG gene set, and calculated k ME values (RG k ME ) for every gene with respect to this RG module ( Supplementary Table 3 ). To facilitate comparisons of RG transcriptional signatures, we mapped all probe sets/ transcripts to a common identifier (HomoloGene ID) and converted RG k ME values for each data set into percentile ranks (RG PR; workflow schematic, Extended Data Fig. 4 ). Genome-wide correlations of RG PR among all data sets ranged from 0.36 to 0.95 (human) and 0.47 to 0.70 (mouse) (P , 2.2 3 10 216 ; Extended Data Fig. 5 ), demonstrating the robustness of RG transcriptional signatures in both species.
To explore the global extent of gene expression conservation between hRG and mRG, we calculated the mean RG specificity for each gene across the five human (hRG PR) three mouse (mRG PR) and all eight (RG PR) data sets ( Supplementary Table 3 ). For genes present in at least one data set in each species (n 5 15,576), the correlation between hRG PR and mRG PR was 0.48 (P , 2.2310 216 ; Fig. 2a ), indicating broad conservation of transcriptional programs that are active during cortical development in humans and mice. Genes with hRG PR and mRG PR .80 ( Fig. 2a, 1RG box) or ,20 ( Fig. 2a , 2RG box) were significantly enriched with sets of genes expressed by RG or neurons, respectively ( Supplementary Table 4 ). Furthermore, the most conserved set of core RG genes (hRG PR and mRG PR .95; Fig. 2a , green box) included the canonical RG markers VIM and PAX6, and SOX family members implicated in nervous system development such as SOX2, SOX3, SOX9 and SOX21 (Fig. 2b) . Also present among this core set were elements of the Notch (NOTCH2 and HES1) and Wnt-b-catenin (SFRP1, FZD8 and LRP4) signalling pathways, which critically regulate neurogenesis 2 . In addition, we observed a cohesive subgroup of genes involved in cell cycle regulation, including CKS2, RACGAP1, MELK, CCNB1, CCNA2, ASPM and MKI67. Finally, several genes in this group have not, to our knowledge, previously been implicated in RG biology, including PSAT1, DDAH1, AIF1L, PSRC1 and ACSS1. Together, these results provide a framework for identifying conserved and distinct aspects of gene expression in hRG and mRG.
To identify evolutionary changes in RG gene expression that might underlie neurodevelopmental differences between human and mouse, we assessed homologous genes based on predicted differences in RG expression specificity between the species (differential RG specificity (DS) 5 hRG PR -mRG PR). Because such differences could emerge from gene expression changes in RG or neighbouring cell types ( Fig. 2c ), we also compared the relative expression levels of homologous genes between the species (differential expression (DE) 5 hEx PR -mEx PR ). Genome-wide analysis of DS/DE revealed four distinct quadrants of genes that differed substantially between human and mouse ( Fig. 2d) . Consistent with the proposed model ( Fig. 2c ), these quadrants were enriched with sets of genes expressed in distinct patterns in developing human and mouse cortex ( Supplementary Table 4 ).
We reasoned that quadrant 1 might contain genes with 'Boolean' expression differences (that is, ON in hRG and OFF in mRG) required for human but not mouse neocortical development. We applied stringent criteria to identify and validate 18 candidate genes in this quadrant with strong and consistent evidence of expression in hRG and no evidence of expression in mRG: ABHD3, ASAP3, BMP7, C5, C8orf4, FAM107A, FOXN4, ITGA2, LRIG3, LRRC17, PAM, PDGFD, PDLIM3, RFTN2, SLC2A10, SP110, STOX1 and ZC3HAV1 (Fig. 2d , cyan circles; see also Extended Data Fig. 6 ). Because secreted growth factors could alter the size of the developing neocortex by influencing proliferation, we focused on PDGFD ( Fig. 2d (right panel) , green square), which has not, to our Table 4 ). Cyan circles highlight 18 genes predicted to be expressed in hRG but not mRG; one of these encodes the growth factor PDGFD (right; green square). Its cognate receptor PDGFRB is also highlighted (right; red square).
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knowledge, previously been implicated in cortical development of any species. Compared to genes with the highest RG PR (conserved in both species), PDGFD expression was highly correlated in human, but not mouse (Fig. 3a, b ). ISH confirmed that PDGFD was expressed by RG throughout the VZ of GW14.5 human neocortex (Fig. 3c ). In contrast, Pdgfd was not detected in RG (or any cell type) in E15.5 mouse neocortex (Fig. 3d ). These expression differences were consistent for multiple ages in human (GW14.5-GW18.2) and mouse (E14.5-E17.5) prenatal cortex (Extended Data Fig. 7) . The effects of PDGFD are specifically mediated by the PDGFRb receptor, which upon phosphorylation can trigger signalling pathways that promote cell proliferation 6, 7, 19 . Although PDGFRB did not meet the same stringent criteria as PDGFD, its location on the DS/DE plot was proximal to PDGFD ( Fig. 2d (right panel) , red square), also suggesting species differences in PDGFRB expression. Compared to genes with the highest RG PR, PDGFRB expression was moderately correlated in human, but not mouse (Fig. 3e, f) . Immunostaining for PDGFRb in GW14.5 human brain revealed strong expression throughout the telencephalic germinal zones (VZ/SVZ) and in vascular pericytes, with highest levels in dorsolateral cortical progenitors and the lateral ganglionic eminence (Fig. 3g) . In contrast, immunostaining for PDGFRb in E15.5 mouse brain revealed expression in lateral ganglionic eminence progenitors but no evidence of expression in cortical progenitors (Fig. 3h ). However, we did observe very low levels of Pdgfrb transcript in the VZ of lateral mouse cortex 20 (Extended Data Fig. 8 ), leaving open the possibility of modest, region-specific function. Collectively, these results indicate that expression patterns of PDGFD and PDGFRb in developing neocortex have diverged considerably during human and mouse evolution, despite retaining amino acid sequences that are ,85% identical between the species.
We tested the requirement of PDGFD-PDGFRb signalling for hRG proliferation in GW17.5 human neocortical slice cultures, screening four chemical inhibitors of PDGFRb signalling (Sutent, tivozanib, imatinib and CP673451). Three out of four PDGFRb inhibitors reduced the percentage of SOX2 1 progenitors (RG) that incorporated 5-bromodeoxyuridine (BrdU) over 2 days in slice culture (Extended Data Fig. 9 ). For replication we focused on CP673451, which exhibits the greatest selectivity for PDGFRb over other receptors 21 
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in SOX2 1 BrdU 1 cells among tested inhibitors (Extended Data Fig. 9 ). PDGFRb inhibition by CP673451 in GW17.5 human neocortical slice cultures reduced the number of RG and intermediate progenitors that incorporated BrdU by .50%, affecting progenitors in the VZ and SVZ (Fig. 4a, b) . The percentage of progenitor cells co-staining with cleaved caspase-3, an apoptosis marker, was slightly elevated by CP673451, but sufficiently low to attribute reduced BrdU incorporation to cell cycle dysregulation rather than cell death (Fig. 4b ). Furthermore, CP673451 treatment of E13.5 mouse cortical slice cultures did not decrease BrdU incorporation or the cycling proportion (Ki67 1 ) of RG or intermediate progenitor populations over multiple time points ( Fig. 4b and Extended Data Fig. 9 ). These results indicate that PDGFRb signalling is required for hRG but not mRG to progress through the cell cycle and expand at a normal rate.
We next investigated whether introducing PDGFD into embryonic mouse cortex, where it is normally absent, could promote mRG proliferation. We injected recombinant PDGF-DD protein into the lateral ventricles of E13.5 mouse embryos, bypassing the need for PDGFD to be generated and dimerized in vivo, and analysed the number and spatial distribution of SOX2 1 progenitors at E15.5 in lateral cortex. Relative to vehicle, PDGF-DD increased the proportion of RG (SOX2 1 DAPI 1 ) in lateral cortex by ,10% (Fig. 4c, d) . Furthermore, PDGF-DD induced a modest subventricular shift in the distribution of mRG in the developing cortical wall (Fig. 4d ). These effects were not observed in dorsomedial Scale bar, 50 mm. The same experiment was performed in E13.5 mouse neocortical slice cultures (slices from at least three individuals/litters per species). b, RG (intermediate progenitor) proliferation was quantified as the fraction of SOX2 1 (TBR2 1 ) cells that incorporated BrdU after 48 h. RG slice counts: human (n 5 18 (DMSO) versus n 5 17 (CP673451)); mouse (n 5 13 (DMSO) versus n 5 11 (CP673451)). Intermediate progenitor slice counts: human (n 5 12 (DMSO) versus n 5 10 (CP673451)); mouse (n 5 11 (DMSO) versus n 5 9 (CP673451)). Cell death was quantified in human slices as the fraction of SOX2 1 or BrdU 1 cells that co-stained for cleaved-caspase 3 (n 5 6 (DMSO) versus n 5 7 (CP673451)). c, In utero intraventricular injection of recombinant human PDGF-DD protein (mouse E13.5-E15.5). Brain tissue was stained for SOX2 and DAPI. Scale bar, 50 mm. d, Quantification of data from c in dorsomedial and lateral cortex (at least n 5 3 slices per embryo from five litters/experiments (lateral: n 5 49 vehicle; n 5 47 PDGF-DD; dorsomedial: n 5 45 vehicle; n 5 39 PDGF-DD)). The distribution of RG in the cortex (from ventricle to pia) was quantified; grey band delineates 95% confidence interval for test of equal univariate densities (n 5 10,000 permutations). e, In utero electroporation of constitutively active PDGFRb(D850V) 22 LETTER RESEARCH cortex, where PDGFRb was not detected in RG (Fig. 4c, d and Extended Data Fig. 8 ).
To test whether mRG can respond to PDGFRb activation, we ectopically expressed two forms of constitutively active PDGFRb (PDGFRb(D850V) (homologous to human D849V (ref. 22)) or the TEL-PDGFRb (ref. 23) fusion protein) in mRG by in utero electroporation at E13.5. By E15.5, expression of PDGFRb(D850V) approximately doubled the proportion of SOX2 1 or Ki67 1 progenitors among electroporated (GFP 1 ) cells and markedly dispersed SOX2 1 progenitors in the basal direction (Fig. 4e, f and Extended Data Fig. 9 ). Similar but less marked effects were observed after TEL-PDGFRb electroporation (Extended Data Fig. 9 ). These results indicate that PDGFRb signalling in mRG can function analogously to its known role as an oncogenic pathway that promotes proliferation and epithelial-mesenchymal transition 19 . We therefore propose that physiological levels of PDGFD-PDGFRb signalling in hRG may contribute to the proliferation and subventricular dispersion of neural progenitors that characterize OSVZ formation 4, 5 .
Mouse studies have demonstrated that the size and shape of cerebral cortex depend on precise regulation of molecular pathways controlling RG proliferation and differentiation 1, 2 . While many of these pathways are probably conserved in humans, mouse studies alone cannot reveal uniquely human aspects of cortical development [24] [25] [26] [27] [28] [29] . By analysing human tissue as a starting point, we found that PDGFD-PDGFRb signalling is required for normal RG proliferation in developing human but not mouse neocortex, and is sufficient to promote some 'humanizing' characteristics in mouse. Our analysis has also identified other genes that probably contribute to differences between human and mouse cortical development. BMP7, another secreted growth factor, was predicted and validated to be expressed by hRG but not mRG ( Fig. 2d and Extended Data Fig. 6 ), raising the possibility that local production of growth factors by hRG may be necessary to support the expanded germinal region and progenitor heterogeneity of developing human neocortex. We anticipate that the analytical and experimental strategies described here will help determine the extent to which these and other pathways are shared among primates or uniquely required for human cortical development.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Table 1 ). The characteristic expression patterns of the superimposed modules were summarized by singular value decomposition; the first principal component (PC1) for each module in each data set is shown. In all cases, PC1 revealed substantially higher expression levels for these genes in germinal zones (VZ, ISVZ, and OSVZ, highlighted in red) versus non-germinal zones (IZ, SP, ICP, OCP, CP, MZ, SG). Permutation analysis indicated that the per cent variance explained (VE) by PC1 of each superimposed module was significantly greater than expected by chance (n 5 10,000 permutations). CP, cortical plate; CTX, cortex; GW, gestational week; ICP, inner cortical plate; ISVZ, inner subventricular zone; IZ, intermediate zone; MZ, marginal zone; OCP, outer cortical plate; OSVZ, outer subventricular zone; SG, subpial granular layer; SP, subplate; VZ, ventricular zone.
Extended Data Figure 5 | Genome-wide predictions of expression specificity for hRG and mRG are robust across independent data sets. a, b, Heat maps of Spearman correlation coefficients for predicted RG expression specificity (RG PR) over 10,929 genes present in all five human data sets (a) and 10,649 genes present in all three mouse data sets (b) (as indicated in columns BE and BI in Supplementary Table 3 ). Data sets are denoted by the sample ages listed in Extended Data Table 1 , although factors besides age also contribute to the observed correlations (for example, choice of technology platform, sample preparation strategy). E, embryonic; GW, gestational week.
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Extended Data Figure 6 | In situ hybridization (ISH) validates predicted presence or absence of gene expression in hRG and mRG. a, Pink box: human in situ probes for six genes predicted to be expressed by hRG but not mRG were generated and hybridized in GW15 human neocortical tissue to validate predicted hRG expression (human scale bar, 200 mm). Blue box (Eurexpress 20 : http://www.eurexpress.org/ee/): in situ hybridizations for 13 genes predicted to be expressed by hRG but not mRG reveal no expression by mRG in E14.5 mouse cortex. Green box: mouse in situ probes for three genes predicted to be expressed by hRG but not mRG were generated and revealed no expression by mRG (E13.5). Positive control expression in cells other than RG are labelled in red. b, Expression patterns of genes predicted to be expressed by mRG (that is, those with the highest mRG PR values in Supplementary  Table 3 ) are shown as further validation (blue (E14.5, Eurexpress 20 : http://www. eurexpress.org/ee/); orange (E14.5, GenePaint: http://www.genepaint.org); mouse scale bars, ,500 mm). One other gene in the top 15, Cks2, is not shown, but has been validated previously 30 .
